Table 2 Overview of the included FA studies and demographics of the included patients
Author | Total (n) | Mean age (SD/range) | Sex (M/F) | WHO grade (n) | b-values (s/mm2) | TP | Mean FA value (SD) | 95% CI | TRA | Mean FA value (SD) | 95%-CI | TP | FP | FN | TN | Sensitivity/ Specificity (%/%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
(n; lesions) | (n; lesions) | |||||||||||||||
Enhancing lesion | Enhancing lesion | |||||||||||||||
Xu et al. (2010) | 35 | 45.2 (21–65) | 19/16 | 2 (4) | b0/1000 | 20 | 0.24 (0.05) | 0.218–0.262 | 15 | 0.14 (0.03) | 0.125–0.155 | 17 | 2 | 3 | 13 | 85/87 |
3 (14) | ||||||||||||||||
4 (17) | ||||||||||||||||
Wang et al. (2016) | 41 | 55.71 (11.83) | 27/14 | 4 (41) | b0/1000 | 21 | 0.14 (0.04) | 0.123–0.157 | 20 | 0.11 (0.03) | 0.0969–0.123 | 15 | 5 | 6 | 15 | 71/75 |
Razek et al | 42 | NR | 13-Nov | 3 (NR) | b0/1000 | 24 | 0.20 (0.04) | 0.184–0.216 | 18 | 0.15 (0.03) | 0.136–0.164 | 20 | 4 | 4 | 14 | 83/78 |
4 (NR) | ||||||||||||||||
Park et al. (2021) | 36 | 52.3 (13.7)(n = 25) 57.1 (14.8)(n = 11) | 18/18 | 2 (3) | b0/1000 | 25 | 0.19 (0.05) | 0.18–0.22 | 11 | 0.16 (0.03) | 0.142–0.178 | 16 | 3 | 9 | 8 | 64/73 |
3 (6) | ||||||||||||||||
4 (27) |